Initially, our analysis revealed a significant elevation in CBX4 transcript levels among HNSCC patients compared to control individuals (p < 0.001), indicating a possible oncogenic role for CBX4 in the progression of HNSCC (Figure 1A). This evidence concerns the gene CBX4 and head and neck squamous cell carcinoma.